Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cataliotti

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|January 16, 2002
Changes of protein kinetics in nephrotic patientsPietro Castellino, Alessandro Cataliotti
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 22, 2005
Natriuretic peptides: novel therapeutic targets in heart failureAlessandro Cataliotti, John C Burnett
Reviews in Cardiovascular Medicine|April 18, 2008
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilatorsFernando L Martin, Horng H Chen, Alessandro Cataliotti, et al.
Trends in Cardiovascular Medicine|January 11, 2007
Oral brain natriuretic peptide: a novel strategy for chronic protein therapy for cardiovascular diseaseAlessandro Cataliotti, Horng H Chen, Kenneth D James, et al.
European Journal of Heart Failure|February 7, 2006
Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failureHorng H Chen, John A Schirger, Alessandro Cataliotti, et al.
Heart Failure Clinics|September 2, 2008
B-type natriuretic peptide: beyond a diagnosticFernando L Martin, Horng H Chen, Alessandro Cataliotti, et al.
Frontiers in Physiology|July 26, 2021
Atrial Natriuretic Peptide<sub>31-67</sub>: A Novel Therapeutic Factor for Cardiovascular DiseasesGustavo Jose Justo da Silva, Raffaele Altara, George W Booz, et al.
Thrombosis and Haemostasis|August 1, 2014
β-blockade abolishes the augmented cardiac tPA release induced by transactivation of heterodimerised bradykinin receptor-2 and β2-adrenergic receptor in vivoTrude Aspelin, Morten Eriksen, Arnfinn Ilebekk, et al.
Peptides|August 17, 2002
Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cellsMichihisa Jougasaki, Amy M Larsen, Alessandro Cataliotti, et al.
Current Medicinal Chemistry|June 25, 2005
Congestive heart failure: pharmacological agents and the potential of B-type natriuretic PeptideKenneth D James, Alessandro Cataliotti, John A Schirger, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Current Opinion in Clinical Nutrition and Metabolic Care|January 16, 2002
Changes of protein kinetics in nephrotic patientsPietro Castellino, Alessandro Cataliotti
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 22, 2005
Natriuretic peptides: novel therapeutic targets in heart failureAlessandro Cataliotti, John C Burnett
Reviews in Cardiovascular Medicine|April 18, 2008
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilatorsFernando L Martin, Horng H Chen, Alessandro Cataliotti, et al.
Trends in Cardiovascular Medicine|January 11, 2007
Oral brain natriuretic peptide: a novel strategy for chronic protein therapy for cardiovascular diseaseAlessandro Cataliotti, Horng H Chen, Kenneth D James, et al.
European Journal of Heart Failure|February 7, 2006
Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failureHorng H Chen, John A Schirger, Alessandro Cataliotti, et al.
Heart Failure Clinics|September 2, 2008
B-type natriuretic peptide: beyond a diagnosticFernando L Martin, Horng H Chen, Alessandro Cataliotti, et al.
Frontiers in Physiology|July 26, 2021
Atrial Natriuretic Peptide<sub>31-67</sub>: A Novel Therapeutic Factor for Cardiovascular DiseasesGustavo Jose Justo da Silva, Raffaele Altara, George W Booz, et al.
Thrombosis and Haemostasis|August 1, 2014
β-blockade abolishes the augmented cardiac tPA release induced by transactivation of heterodimerised bradykinin receptor-2 and β2-adrenergic receptor in vivoTrude Aspelin, Morten Eriksen, Arnfinn Ilebekk, et al.
Peptides|August 17, 2002
Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cellsMichihisa Jougasaki, Amy M Larsen, Alessandro Cataliotti, et al.
Current Medicinal Chemistry|June 25, 2005
Congestive heart failure: pharmacological agents and the potential of B-type natriuretic PeptideKenneth D James, Alessandro Cataliotti, John A Schirger, et al.
Pageof 10